Literature DB >> 2478132

Isolation and characterization of a mouse L cell variant deficient in glucocorticoid receptors.

P R Housley1, A M Forsthoefel.   

Abstract

The growth of mouse L cell fibroblasts is inhibited by glucocorticoids, and we have selected spontaneous glucocorticoid-resistant L cells in culture. One cloned variant exhibits a stable phenotype in the absence of selective conditions. This variant contains no specific glucocorticoid-binding capacity, no immunoreactive glucocorticoid receptor protein, and no detectable glucocorticoid receptor messenger RNA. A glucocorticoid-dependent reporter gene requires exogenous glucocorticoid receptor cDNA and steroid in order to be expressed in this variant. Genomic DNA analysis of the variant cell line indicates that there has been no gross alteration in receptor gene structure. These results suggest that the variant may be deficient in transcription of the glucocorticoid receptor gene.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2478132     DOI: 10.1016/0006-291x(89)91745-2

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Attenuation of glucocorticoid receptor levels by the H-ras oncogene.

Authors:  V R Martins; M M Brentani; P R Housley
Journal:  Endocrine       Date:  1995-04       Impact factor: 3.633

2.  c-Myb interacts with the glucocorticoid receptor and regulates its level in pre-B-acute lymphoblastic leukemia cells.

Authors:  Purvaba J Sarvaiya; Jason R Schwartz; Chuan-dong Geng; Wayne V Vedeckis
Journal:  Mol Cell Endocrinol       Date:  2012-04-10       Impact factor: 4.102

3.  VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects.

Authors:  Christopher R Heier; Jesse M Damsker; Qing Yu; Blythe C Dillingham; Tony Huynh; Jack H Van der Meulen; Arpana Sali; Brittany K Miller; Aditi Phadke; Luana Scheffer; James Quinn; Kathleen Tatem; Sarah Jordan; Sherry Dadgar; Olga C Rodriguez; Chris Albanese; Michael Calhoun; Heather Gordish-Dressman; Jyoti K Jaiswal; Edward M Connor; John M McCall; Eric P Hoffman; Erica K M Reeves; Kanneboyina Nagaraju
Journal:  EMBO Mol Med       Date:  2013-09-09       Impact factor: 12.137

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.